Cargando…
Targeting copper metabolism to defeat KRAS-driven colorectal cancer
KRAS-driven cancers acquire profound metabolic dependencies that are intimately linked to tumor growth. Our work revealed that colorectal cancers that harbor KRAS mutations are addicted to copper metabolism. This adaptation renders tumor cells critically dependent on the copper transporter ATP7A, wh...
Autores principales: | Aubert, Léo, Nandagopal, Neethi, Roux, Philippe P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671051/ https://www.ncbi.nlm.nih.gov/pubmed/33235918 http://dx.doi.org/10.1080/23723556.2020.1822123 |
Ejemplares similares
-
Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
por: Aubert, Léo, et al.
Publicado: (2020) -
Breaking bad family ties: Pan-ERBB blockers inhibit KRAS driven lung tumorigenesis
por: Moll, Herwig P., et al.
Publicado: (2018) -
A mechanism for the response of KRAS(G13D) expressing colorectal cancers to EGFR inhibitors
por: McFall, Thomas, et al.
Publicado: (2020) -
COBRA methods and metabolic drug targets in cancer
por: Apaolaza, Iñigo, et al.
Publicado: (2017) -
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
por: Thibaudin, Marion, et al.
Publicado: (2023)